we create mRNA therapies that instruct specific cells on how to make their own medicine
Kernal Biologics is a VC-backed startup developing cell specific mRNA therapies. Kernal Biologics was founded by scientists and entrepreneurs with a broad range of experience in synthetic biology, immuno-oncology, and deep learning.
Our vision is to develop curative immunotherapies for cancers and COVID-19 by using deep learning and synthetic biology.
Thanks to our mRNA 2.0 technology, our proprietary platform decreases immunogenicity upon existing mRNA technologies and enables cell-specific therapeutic protein expression. This allows us to design and develop more efficacious, tolerable, and affordable medicine for the global market.